Array.
Iran university of medical sciences.
Acta Biomed. 2020 Nov 10;91(4):e2020146. doi: 10.23750/abm.v91i4.10183.
Coronavirus disease 2019(COVID-19) is an acute respiratory illness, caused by Severe Acute Respiratory Syndrome Coronavirus2 (SARS-COV2) which quickly grew to a pandemic in late 2019 and led to substantial public health problems. Among the extrapulmonary manifestations reported, cardiovascular implications are remarkable as they can be potentially lethal. There have been rare reports of pericardial involvement, despite the pronounced cardiovascular complications including acute myocardial injury, myocarditis, arrhythmia, cardiogenic shock and venous thromboembolism. Herein, we reported a young man with cardiac tamponade as the presenting feature of COVID-19. Case summary: An otherwise healthy 28-year-old man, was admitted with pleuritic chest pain and shortness of breath and was diagnosed with COVID-19 associated cardiac tamponade. Emergency pericardiocentesis yielded large amount of hemorrhagic pericardial effusion which resulted in symptom relief. He was successfully treated with pericardiocentesis followed by anti-viral and anti-inflammatory medications and remained asymptomatic in 1-month follow-up.
We highlight this case to mention that "hemorrhagic" cardiac tamponade can be a life-threatening complication of COVID-19, which can be treated if diagnosed early. Therefore, clinicians should be fully aware of this cardiac complication to consider in deteriorating COVID-19 patients.
2019 年冠状病毒病（COVID-19）是一种急性呼吸道疾病，由严重急性呼吸系统综合症冠状病毒 2（SARS-COV2）引起，该病毒在 2019 年末迅速发展为大流行，并导致了严重的公共卫生问题。在报告的肺外表现中，心血管并发症引人注目，因为它们可能是致命的。尽管包括急性心肌损伤、心肌炎、心律失常、心源性休克和静脉血栓栓塞在内的心血管并发症明显，但心包受累的罕见报告。在此，我们报告了一例以 COVID-19 为特征的心脏压塞的年轻男性病例。病例总结：一名无其他疾病的 28 岁男性，因胸痛和呼吸急促而入院，被诊断为 COVID-19 相关心脏压塞。紧急心包穿刺术获得了大量血性心包积液，导致症状缓解。他成功地接受了心包穿刺术，随后接受了抗病毒和抗炎药物治疗，在 1 个月的随访中无症状。结论：我们强调这个病例是为了说明“血性”心脏压塞可能是 COVID-19 的一种危及生命的并发症，如果及早诊断可以得到治疗。因此，临床医生应该充分认识到这种心脏并发症，以考虑在病情恶化的 COVID-19 患者中。
